Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Wijnanda A. Kors"'
Autor:
Stephanie van Straaten, Marc Bierings, Paola Bianchi, Kensuke Akiyoshi, Hitoshi Kanno, Isabel Badell Serra, Jing Chen, Xiaohang Huang, Eduard van Beers, Supachai Ekwattanakit, Tayfun Güngör, Wijnanda Adriana Kors, Frans Smiers, Reinier Raymakers, Lucrecia Yanez, Julian Sevilla, Wouter van Solinge, Jose Carlos Segovia, Richard van Wijk
Publikováno v:
Haematologica, Vol 103, Iss 2 (2018)
Externí odkaz:
https://doaj.org/article/a1bb799c0c6748d08f56701f823ceb7e
Autor:
Jan Loeffen, Saskia M. J. Hopman, Natasha K. A. van Eijkelenburg, Cora M. Aalfs, Fonnet E. Bleeker, Lieke P.V. Berger, Peter Hammond, Floor A. M. Postema, Charlotte J. Dommering, Jakob K. Anninga, Janna A. Hol, Raoul C.M. Hennekam, Anja Wagner, Maran J. W. Olderode-Berends, Marry M. van den Heuvel-Eibrink, Tom G.W. Letteboer, Lisethe Meijer, Johannes H. M. Merks, Corianne A. J. M. de Borgie, Wijnanda A. Kors
Publikováno v:
Familial Cancer, 20, 263-271. SPRINGER
Familial Cancer
Familial Cancer, 20(4), 263-271. Springer Netherlands
Postema, F A M, Hopman, S M J, de Borgie, C A J M, Aalfs, C M, Anninga, J K, Berger, L P V, Bleeker, F E, Dommering, C J, van Eijkelenburg, N K A, Hammond, P, van den Heuvel-Eibrink, M M, Hol, J A, Kors, W A, Letteboer, T G W, Loeffen, J L C M, Meijer, L, Olderode-Berends, M J W, Wagner, A, Hennekam, R C & Merks, J H M 2021, ' Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS) : a prospective, observational, multi-center study ', Familial Cancer, vol. 20, no. 4, pp. 263-271 . https://doi.org/10.1007/s10689-021-00237-1
Familial Cancer
Familial Cancer, 20(4), 263-271. Springer Netherlands
Postema, F A M, Hopman, S M J, de Borgie, C A J M, Aalfs, C M, Anninga, J K, Berger, L P V, Bleeker, F E, Dommering, C J, van Eijkelenburg, N K A, Hammond, P, van den Heuvel-Eibrink, M M, Hol, J A, Kors, W A, Letteboer, T G W, Loeffen, J L C M, Meijer, L, Olderode-Berends, M J W, Wagner, A, Hennekam, R C & Merks, J H M 2021, ' Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS) : a prospective, observational, multi-center study ', Familial Cancer, vol. 20, no. 4, pp. 263-271 . https://doi.org/10.1007/s10689-021-00237-1
Recognizing a tumor predisposition syndrome (TPS) in a child with cancer is of clinical relevance. Earlier we developed a screening tool to increase diagnostic accuracy and clinical efficiency of identifying TPSs in children with cancer. Here we repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67cce1624134f5a9b26b091ecb172ecd
https://doi.org/10.1007/s10689-021-00237-1
https://doi.org/10.1007/s10689-021-00237-1
Autor:
Sutaryo Sutaryo, Pudjo Hagung Widjajanto, Sri Mulatsih, Bambang Ardianto, Alexandra Widita Swipratami Pangarso, Eddy Supriyadi, Ignatius Purwanto, Claudia Priska Adelin, Rahmadani Puji Lestari, Lintang Sagoro, Scholastika Dita Christian, Dea Sella Sabrina, Natasha Verena, Wijnanda Adriana Kors, Gertjan J. L. Kaspers, Anjo J. P. Veerman
Publikováno v:
Sutaryo, S, Widjajanto, P H, Mulatsih, S, Ardianto, B, Pangarso, A W S, Supriyadi, E, Purwanto, I, Adelin, C P, Lestari, R P, Sagoro, L, Christian, S D, Sabrina, D S, Verena, N, Kors, W A, Kaspers, G J L & Veerman, A J P 2022, ' Childhood acute lymphoblastic leukemia : Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country ', Pediatric Blood and Cancer, vol. 69, no. 11, e29875 . https://doi.org/10.1002/pbc.29875
Pediatric Blood and Cancer, 69(11):e29875. Wiley-Liss Inc.
Pediatric Blood and Cancer, 69(11):e29875. Wiley-Liss Inc.
Background: The prognosis of childhood acute lymphoblastic leukemia (ALL) in Indonesia, a lower-middle-income country (LMIC), is lower than in high income countries (HICs). The Indonesian ALL2013 protocol resulted in too many toxic deaths (21%) and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c640beea4c8c8ae51ca353c9b4d695
https://research.vumc.nl/en/publications/92fd7004-8690-4b2a-9efe-752430088500
https://research.vumc.nl/en/publications/92fd7004-8690-4b2a-9efe-752430088500
Autor:
Krisna Handayani, Sri Mulatsih, Saskia Mostert, Gertjan J.L. Kaspers, Braghmandita Widya Indraswari, Mei Neni Sitaresmi, Wijnanda A. Kors, Pudjo Hagung Widjajanto
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Handayani, K, Indraswari, B W, Sitaresmi, M N, Mulatsih, S, Widjajanto, P H, Kors, W A, Kaspers, G J & Mostert, S 2021, ' Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia ', Asian Pacific journal of cancer prevention : APJCP, vol. 22, no. 5, pp. 1613-1621 . https://doi.org/10.31557/APJCP.2021.22.5.1613
Asian Pacific journal of cancer prevention : APJCP, 22(5), 1613-1621
Handayani, K, Indraswari, B W, Sitaresmi, M N, Mulatsih, S, Widjajanto, P H, Kors, W A, Kaspers, G J & Mostert, S 2021, ' Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia ', Asian Pacific journal of cancer prevention : APJCP, vol. 22, no. 5, pp. 1613-1621 . https://doi.org/10.31557/APJCP.2021.22.5.1613
Asian Pacific journal of cancer prevention : APJCP, 22(5), 1613-1621
Background: Although survival rates for retinoblastoma (RB) are over 95% in high-income countries, its high mortality rate in low and middle-income countries remains a great concern. Few studies investigated treatment outcome and factors contributing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5870b52425dc5fbd93381d9865c88b29
https://doi.org/10.31557/apjcp.2021.22.5.1613
https://doi.org/10.31557/apjcp.2021.22.5.1613
Autor:
Furqan Shaikh, Wijnanda A. Kors, Brenda L. Gallie, Annette C. Moll, Tero Kivelä, Robin W. Jansen, Helen Dimaras, Pim de Graaf, Sameh E. Soliman, Marcus C. de Jong, Jonas A. Castelijns
Publikováno v:
Ophthalmology. 127:601-607
Topic To determine the age up to which children are at risk of trilateral retinoblastoma (TRb) developing, whether its onset is linked to the age at which intraocular retinoblastomas develop, and the lead time from a detectable pineal TRb to symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dfece3aeb9f91c12bfaf3892f877ece
https://doi.org/10.1016/j.ophtha.2019.10.040
https://doi.org/10.1016/j.ophtha.2019.10.040
Autor:
Charlotte J. Dommering, Brenda L. Gallie, Helen Dimaras, Sameh E. Soliman, Tero Kivelä, Wijnanda A. Kors, Robin W. Jansen, Marcus C. de Jong, Manohar Shroff, Furqan Shaikh, Pim de Graaf, Annette C. Moll
Publikováno v:
de Jong, M C, Shaikh, F, Gallie, B, Kors, W A, Jansen, R W, Dommering, C, de Graaf, P, Moll, A C, Dimaras, H, Shroff, M, Kivelä, T T & Soliman, S E 2022, ' Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma : a meta-analysis ', Acta Ophthalmologica, vol. 100, no. 1, pp. e47-e52 . https://doi.org/10.1111/aos.14855
Acta Ophthalmologica, 100(1), e47-e52. Wiley-Blackwell
Acta Ophthalmologica, 100(1), e47-e52. Wiley-Blackwell
PURPOSE: To determine the risk of patients with an early diagnosis of heritable retinoblastoma being diagnosed with TRb (or pineoblastoma) asynchronously in a later stage and its effect on screening.METHODS: We updated the search (PubMed and Embase)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5913c1b8c9989d1940f317b55cd40576
http://hdl.handle.net/10138/353312
http://hdl.handle.net/10138/353312
Autor:
Annette C. Moll, Lindsay M. Morton, Charlotte J. Dommering, Michael Walsh, Machteld I. Bosscha, Kevin C. Oeffinger, Ruth A. Kleinerman, Ira J. Dunkel, Danielle Novetsky Friedman, Flora E. van Leeuwen, Mary-Louise C. Greer, Petra Temming, Dana Barnea, Pim de Graaf, Margaret A. Tucker, Guillermo L. Chantada, Armida W. M. Fabius, Suzanne Laughlin, Emily S. Tonorezos, David H. Abramson, Wijnanda A. Kors, Jasmine H. Francis
Publikováno v:
Ophthalmology
Tonorezos, E S, Friedman, D N, Barnea, D, Bosscha, M I, Chantada, G, Dommering, C J, de Graaf, P, Dunkel, I J, Fabius, A W M, Francis, J H, Greer, M-L C, Kleinerman, R A, Kors, W A, Laughlin, S, Moll, A C, Morton, L M, Temming, P, Tucker, M A, van Leeuwen, F E, Walsh, M F, Oeffinger, K C & Abramson, D H 2020, ' Recommendations for long-term follow-up of adults with heritable retinoblastoma ', Ophthalmology, vol. 127, no. 11, pp. 1549-1557 . https://doi.org/10.1016/j.ophtha.2020.05.024
Ophthalmology, 127(11), 1549-1557. Elsevier Inc.
Tonorezos, E S, Friedman, D N, Barnea, D, Bosscha, M I, Chantada, G, Dommering, C J, de Graaf, P, Dunkel, I J, Fabius, A W M, Francis, J H, Greer, M-L C, Kleinerman, R A, Kors, W A, Laughlin, S, Moll, A C, Morton, L M, Temming, P, Tucker, M A, van Leeuwen, F E, Walsh, M F, Oeffinger, K C & Abramson, D H 2020, ' Recommendations for long-term follow-up of adults with heritable retinoblastoma ', Ophthalmology, vol. 127, no. 11, pp. 1549-1557 . https://doi.org/10.1016/j.ophtha.2020.05.024
Ophthalmology, 127(11), 1549-1557. Elsevier Inc.
OBJECTIVE: Generate recommendations for long-term follow-up for adult survivors of heritable retinoblastoma.DESIGN: We convened a meeting of providers from retinoblastoma centers around the world to review the state of the science and to evaluate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53aad679a5de9958e2b36b1dcb515cd
https://pubmed.ncbi.nlm.nih.gov/32422154
https://pubmed.ncbi.nlm.nih.gov/32422154
Autor:
Armida W. M. Fabius, Wijnanda A. Kors, Annette C. Moll, Ton Houffelaar, Machteld I. Bosscha, Nuray A. McNeill, Irma M. Verdonck-de Leeuw, Jennifer van Dijk
Publikováno v:
Journal of Cancer Survivorship, 11(6), 683-690. Springer New York
Journal of Cancer Survivorship
McNeill, N A, Kors, W A, Bosscha, M I, van Dijk, J, Fabius, A W M, Houffelaar, T, Verdonck-de Leeuw, I M & Moll, A C 2017, ' Feasibility of RetinoQuest : e-health application to facilitate and improve additional care for retinoblastoma survivors ', Journal of Cancer Survivorship, vol. 11, no. 6, pp. 683-690 . https://doi.org/10.1007/s11764-017-0642-z
Journal of Cancer Survivorship
McNeill, N A, Kors, W A, Bosscha, M I, van Dijk, J, Fabius, A W M, Houffelaar, T, Verdonck-de Leeuw, I M & Moll, A C 2017, ' Feasibility of RetinoQuest : e-health application to facilitate and improve additional care for retinoblastoma survivors ', Journal of Cancer Survivorship, vol. 11, no. 6, pp. 683-690 . https://doi.org/10.1007/s11764-017-0642-z
Purpose The current study aimed to evaluate the feasibility of RetinoQuest in clinical practice, from survivors and healthcare professionals’ (HCPs) point of view. Methods RetinoQuest is a touch screen computer program to monitor health-related qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb3ee71af38e60ff609da93dc9b91d2
https://doi.org/10.1007/s11764-017-0642-z
https://doi.org/10.1007/s11764-017-0642-z
Publikováno v:
Geurtsen, M L, Kors, W A, Moll, A C & Smits, C 2017, ' Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma ', Ophthalmic Genetics, pp. 1-5 . https://doi.org/10.3109/13816810.2015.1137325
Ophthalmic Genetics, 1-5. Taylor and Francis Ltd.
STARTPAGE=1;ENDPAGE=5;ISSN=1381-6810;TITLE=Ophthalmic Genetics
Ophthalmic Genetics, 1-5. Taylor and Francis Ltd.
STARTPAGE=1;ENDPAGE=5;ISSN=1381-6810;TITLE=Ophthalmic Genetics
BACKGROUND: Children treated for retinoblastoma with carboplatin have an increased risk for ototoxicity. Impaired hearing may have major consequences for these children, because they often suffer from reduced vision. Previous studies have shown limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d31804dd2fd8af828cbbdbf8effa63
https://doi.org/10.3109/13816810.2015.1137325
https://doi.org/10.3109/13816810.2015.1137325
Autor:
Charlotte J. Dommering, Machteld I. Bosscha, Annette C. Moll, Gertjan J.L. Kaspers, Maarten P.G. Massink, Josephine C. Dorsman, Berber M. Mol, Hanne Meijers-Heijboer, Jacqueline Cloos, Annemarie H. van der Hout, Johannes M. A. Zaman, Hein te Riele, Wijnanda A. Kors
Publikováno v:
Genes, Chromosomes and Cancer. 53:1-14
Both hereditary and nonhereditary retinoblastoma (Rb) are commonly initiated by loss of both copies of the retinoblastoma tumor suppressor gene (RB1), while additional genomic changes are required for tumor initiation and progression. Our aim was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae37237621781ca32d7b76fed2e2e25a
https://doi.org/10.1002/gcc.22111
https://doi.org/10.1002/gcc.22111